How it works
Every public claim your brand makes is read three times: against 98 published standards, by the AI engine behind our phrase-ruling database, and by a licensed pharmacist who signs the result.
$2,000 flat, five business days. Nothing needed from you but URLs. This page walks through the audit and the file it produces, from order to delivery.
Who asks
The FDA, the FTC and Health Canada write the rules. Every gatekeeper reads them. Enforcement arrives late, and in public. We apply the same rules first, in private, on your side.
The rules · FDA, FTC, Health Canada and platform policy→One signed file
Claim territory
Most brands hedge into language so soft it converts nothing. A minority overreach into claims that draw enforcement. The permitted middle is wider than either group assumes, and it is where the revenue is.
Swipe the table to see all three columns →
| What you say now | What you may say · permitted | Competitors say · draws enforcement |
|---|---|---|
| “Supports wellness.” | “Helps maintain healthy sleep cycles and supports a normal stress response.” | “ |
| “Made with quality ingredients.” | “Third-party tested for identity and potency in an ISO 17025 laboratory.” | “ |
| “May help you relax.” | “Promotes relaxation before bedtime.” | “ |
| “A gentle formula.” | “Formulated without habit-forming ingredients.” | “ |
| Converts poorly · no enforcement risk | Converts and defensible · where we put you | Converts until it doesn’t · warning letter, suppression |
The middle column is not defensive spend. It is claim strength you were already entitled to and were not using, applied to the copy that does your selling.
What we read
The review is external and read-only. You hand us URLs. We read every claim a regulator, platform or acquirer would.
Access and confidentiality
The audit is built to be safe to commission. It runs entirely on what the public can already see, and it is reported to you alone.
We read: public surfaces only
We never touch
Read-only and external. Reported to you alone, confidential and never shared.
The three passes
Nothing is sampled. Every phrase on every surface takes all three passes, and no finding ships until the third one signs it.
98, drawn from thirteen rulebooks
Every claim is ruled against all 98 banned-phrase standards, drawn from FDA structure/function rules (21 CFR 101.93 · 21 U.S.C. §343(r)(6)), FTC Act §5 substantiation, Amazon seller policy, and Meta and Google ad rules.
The engine behind 149,000+ phrase checks
The engine that has run 149,000+ phrase checks across the top-selling listings in every category we track reads your pages in hours, not weeks. It flags named conditions, drug claims, certification claims and superlatives, and cross-references the FDA warning-letter database.
Pharmacist-in-the-loop
A licensed pharmacist reviews every finding, sets its severity, and signs the verdict and the rewrite. The machine does the sweep. A licensed professional owns every verdict. That signature is what you hand a retailer, a payment processor or an acquirer.
The rules are written down, which is why the same phrase gets the same ruling for every brand. Our AI checks your copy against all 98 standards at once, which is how one sentence can turn up failing four different rules. Nothing ships unsigned. The standard’s categories, sources and ruling format are on the standards page; the full rule text ships inside every report, and publishes in full with the directory.
The severity scale
Three severity grades tell you what to fix first. Critical findings are the ones that draw warning letters and takedowns.
One finding, in full
Pulled from a live scan of a sleep-category listing. Every finding in your report is formatted exactly like this.
CriticalNamed condition · sample finding
Source: Amazon A+ contentAs published
“…has also been shown to soothe anxiety.”
Compliant rewrite
“Promotes a sense of calm and supports restful sleep.”
Ruling“Anxiety” is a named disease state. Treating it turns the product into an unapproved drug under 21 U.S.C. §343(r)(6), a claim pattern that appears throughout published FDA warning letters to supplement brands. The rating and rewrite carry a pharmacist’s signature, not a model’s guess.
What each half does for the P&L: the strikethrough takes a disease claim off your best-selling page, and the rewrite keeps the promise customers respond to. Removing the claim does not cost you the sentence that sells.
The report, page by page
A findings file built to be handed onward: to your copywriter to fix, to counsel to rely on, to a platform appeal or an acquirer’s data room as-is.
The five days
What you receive
Claims are a revenue line, not a legal line
The audit is five days of reading. What it is bought for is everything below, none of which arrives as a fine.
A suppressed ASIN earns nothing from the hour it happens, and the way back is an appeal built from evidence you either have or do not.
A processor review puts a reserve on the account. The revenue is yours and you still cannot spend it, and the reviewer wants documentation, not an explanation.
A restricted ad account ends paid traffic on the day it happens, and the flag attaches to the account rather than the ad, so it follows every later campaign.
Claim exposure is a diligence line. An acquirer prices what it cannot verify, and a signed file is the difference between a discount and a clean close.
The other direction
Every failing line comes back as the strongest wording the rules allow. The point is rarely to say less.
The claims that passed, in writing, so the next campaign does not reopen what the audit closed.
The one number that tells you whether this is urgent for you or merely tidy.
Remove what takes revenue away. Keep the strongest claim you are allowed to make.
Before you ask
No. We are not a regulator and we report to you alone. Nothing we find is disclosed to Amazon, Meta, the FDA or the FTC. The exposure already exists in your live copy. The audit tells you where, before someone else finds it.
An ASIN or product URL, plus the ad creative and email flows you forward to us for scope. No account access of any kind: the review is entirely external and read-only, no Seller Central access, nothing installed. Your time to start is about ten minutes; $500 starts the audit and the rest is due on delivery.
That is your commercial decision. Every finding carries a severity so you can triage: Critical findings are the ones that draw warning letters and suppressions. Some brands fix only those and accept the rest knowingly, which is a defensible position.
Request
$2,000 flat. Five business days. $500 to start, the rest on delivery, and if we find nothing Critical, we say so in writing.